Adverum Biotechnologies shares are trading higher after Mizuho initiated coverage on the stock with a Buy rating and announced a $2 price target.
Portfolio Pulse from Benzinga Newsdesk
Adverum Biotechnologies' stock is trading higher following Mizuho's initiation of coverage with a Buy rating and a $2 price target.
November 02, 2023 | 4:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adverum Biotechnologies' stock price is likely to increase in the short term due to Mizuho's positive coverage initiation and price target.
Mizuho's initiation of coverage with a Buy rating and a $2 price target for Adverum Biotechnologies is a strong positive signal for the stock. This is likely to attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100